Journal
ARRHYTHMIA & ELECTROPHYSIOLOGY REVIEW
Volume 7, Issue 2, Pages 128-134Publisher
RADCLIFFE CARDIOLOGY
DOI: 10.15420/aer.2018.23.2
Keywords
Premature ventricular complex; cardiomyopathy; ventricular dysfunction; heart failure; palpitations; arrhythmia; radiofrequency catheter ablation; antiarrhythmic drug; outflow tract; non-sustained ventricular tachycardia
Categories
Ask authors/readers for more resources
Premature ventricular complex-induced cardiomyopathy is a potentially reversible condition in which left ventricular dysfunction is induced by the occurrence of frequent premature ventricular complexes (PVCs). Various cellular and extracellular mechanisms and risk factors for developing cardiomyopathy in this context have been suggested but the exact pathophysiological mechanism remains unclear. The suppression of PVCs is usually indicated in symptomatic patients with frequent PVCs and also those with left ventricular dysfunction. Antiarrhythmic drugs are a useful non-invasive treatment to eliminate PVCs, but the side effect profile, including the risk of pro-arrhythmia, along with suboptimal clinical effectiveness, should be weighed against the usually more effective but not risk-free treatment with catheter ablation. The latter has progressively become first line therapy in many patients with PVC-induced cardiomyopathy and should be particularly considered in specific scenarios.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available